We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Lysyl Oxidase–Like 1 Gene in the Reversal of Promoter Risk Allele in Pseudoexfoliation Syndrome

Sushil Kumar Dubey, MSc1; J. Fielding Hejtmancik, MD, PhD2; Subbaiah Ramasamy Krishnadas, DNB3; Rajendrababu Sharmila, DNB3; Aravind Haripriya, MS4; Periasamy Sundaresan, PhD1
[+] Author Affiliations
1Department of Genetics, Aravind Medical Research Foundation, Dr G. Venkataswamy Eye Research Institute, Madurai, India
2Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Rockville, Maryland
3Glaucoma Clinic, Aravind Eye Hospital, Madurai, India
4Intraocular Lens and Cataract Clinic, Aravind Eye Hospital, Madurai, India
JAMA Ophthalmol. 2014;132(8):949-955. doi:10.1001/jamaophthalmol.2014.845.
Text Size: A A A
Published online

Importance  This study was necessary to establish the association between common genetic variants in the lysyl oxidase–like 1 (LOXL1) gene with pseudoexfoliation (PEX) syndrome and emphasize the reversal of promoter risk allele in a South Indian population.

Objective  To investigate the potential association of genetic variants across the LOXL1 gene in South Indian patients with PEX syndrome and glaucoma.

Design, Setting, and Participants  A case-control study of individuals from Madurai, India, with PEX syndrome and glaucoma as well as healthy people serving as controls. Three hundred unrelated people with PEX syndrome and 225 age- and ethnically matched controls were recruited for genetic analysis.

Main Outcomes and Measures  Four single-nucleotide polymorphisms in LOXL1 (rs16958477, rs1048661, rs3825942, and rs2165241) were genotyped by direct sequencing in all participants. Regulatory regions and 7 coding exons of LOXL1 were directly sequenced in 50 patients and 50 controls. A case-control association analysis was performed using the Golden Helix SVS suite.

Results  An association between 4 LOXL1 single-nucleotide polymorphisms with PEX syndrome and glaucoma was observed (rs16958477, P = 4.77 × 10−6 [odds ratio, 0.50]; rs1048661, P = 4.28 × 10−5 [1.79]; rs3825942, P = 4.68 × 10−30 [9.19]; and rs2165241, P = 1.98 × 10−15 [2.88]). Sequencing of 7 exons and regulatory regions of LOXL1 identified 11 additional sequence variants; only rs41435250 showed an association (P = 3.80 × 10−5 [0.49]) with PEX syndrome and glaucoma.

Conclusions and Relevance  Genetic variants in LOXL1 are associated with PEX syndrome and glaucoma in the South Indian population. To our knowledge, this is the first study to demonstrate the association of rs41435250 with PEX as well as reversal of the promoter risk allele. Understanding the role of the LOXL1 gene in PEX pathogenesis will facilitate early detection in individuals at risk for this condition.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?


Place holder to copy figure label and caption
Linkage Disequilibrium Plot of LOXL1

The linkage disequilibrium plot of 5 LOXL1 single-nucleotide polymorphisms was calculated using Haploview. The D′ values are greater than 0.7 for all pairs.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature
How Can I Apply the Results to Patient Care?

Users' Guides to the Medical Literature